Okay.
The regulations are obviously not in force right now. I think it's fair to say that the main concern about these proposed regulations is the potential impact on access. We know there's a problem with access now because clearly we have patient groups all across this country who can't get access to the medication they want. Trikafta was mentioned as a famous example, and patients aren't getting access to that drug under the current regulations without these proposed changes to the PMPRB.
I'll put a thesis to you. In a system where we have finite resources—i.e., in Canada—we can only spend a certain amount of money every year on pharmaceutical products. Wouldn't controlling excessive costs help provide greater access to drugs than not?